The Inducible Nitric Oxide Synthase Pathway Promotes Osteoclastogenesis under Hypoxic Culture Conditions

Am J Pathol. 2021 Dec;191(12):2072-2079. doi: 10.1016/j.ajpath.2021.08.014. Epub 2021 Sep 21.

Abstract

Bone homeostasis depends on the balance between bone resorption by osteoclasts (OCs) and bone formation by osteoblasts. Bone resorption can become excessive under various pathologic conditions, including rheumatoid arthritis. Previous studies have shown that OC formation is promoted under hypoxia. However, the precise mechanisms behind OC formation under hypoxia have not been elucidated. The present study investigated the role of inducible nitric oxide synthase (iNOS) in OC differentiation under hypoxia. Primary bone marrow cells obtained from mice were stimulated with receptor activator of NF-κB ligand and macrophage colony-stimulating factor to induce OC differentiation. The number of OCs increased in culture under hypoxia (oxygen concentration, 5%) compared with that under normoxia (oxygen concentration, 20%). iNOS gene and protein expression increased in culture under hypoxia. Addition of an iNOS inhibitor under hypoxic conditions suppressed osteoclastogenesis. Addition of a nitric oxide donor to the normoxic culture promoted osteoclastogenesis. Furthermore, insulin-like growth factor 2 expression was significantly altered in both iNOS inhibition experiments and nitric oxide donor experiments. These data might provide clues to therapies for excessive osteoclastogenesis under several hypoxic pathologic conditions, including rheumatoid arthritis.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Bone Resorption / genetics
  • Bone Resorption / metabolism
  • Cell Differentiation / drug effects
  • Cell Differentiation / genetics
  • Cell Hypoxia / drug effects
  • Cell Hypoxia / physiology*
  • Cells, Cultured
  • Enzyme Induction / drug effects
  • Enzyme Induction / genetics
  • Hypoxia / genetics
  • Hypoxia / metabolism
  • Hypoxia / pathology
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Nitric Oxide Synthase Type II / antagonists & inhibitors
  • Nitric Oxide Synthase Type II / genetics
  • Nitric Oxide Synthase Type II / metabolism
  • Nitric Oxide Synthase Type II / physiology*
  • Osteoclasts / drug effects
  • Osteoclasts / physiology*
  • Osteogenesis / drug effects
  • Osteogenesis / genetics
  • Oxygen / pharmacology
  • Signal Transduction / drug effects
  • Signal Transduction / physiology
  • omega-N-Methylarginine / pharmacology

Substances

  • omega-N-Methylarginine
  • Nitric Oxide Synthase Type II
  • Nos2 protein, mouse
  • Oxygen